Albany, NY -- (SBWIRE) -- 06/06/2017 -- The global pain management therapeutics market has been studied based on major segments by therapeutics, by indication and their regional as well as national markets. Based on therapeutics, the global market has been segmented into anticonvulsants, antidepressants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, other non-narcotic analgesic, and antimigraine agents. Further the market has been segmented according to its indication that includes neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain, and cancer pain. The market for these segments has been extensively analyzed based on their effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.
This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the general information and data analysis of the global pain management therapeutics market with respect to the leading market segments based on major therapeutics, and geographies.
The market overview section of the report explores the dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pain management therapeutics market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition across different geographies. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their position and expand their shares in the global pain management therapeutics market.
This exhaustive report includes 13 data tables and 64 figures to give readers a 360° view of the Pain Management Therapeutics Market. Browse through this 130-page report to know what factors will shape the market during the period 2016-2024
http://www.transparencymarketresearch.com/pain-management-therapeutics.html
Geographically, the pain management therapeutics market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World(RoW). Each regional pain management therapeutics market has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., Japan, China, Brazil, and Mexico. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.
The recommendations section included in the report would assist existing market players to expand their market shares, and new companies in establishing their presence in the global pain management therapeutics market. The report also profiles key players operating in this market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited.
The global pain management therapeutics market is segmented as follows:
Global Pain Management Therapeutics Market Revenue, by Therapeutics
Anticonvulsants
Antidepressants
Anesthetics
Non-steroidal Anti-inflammatory Drugs (NSAIDS)
Opioids
Oxycodones
Hydrocodones
Tramadol
Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
Antimigraine Agents
Other Non-narcotic Analgesic
Global Pain Management Therapeutics Market Revenue, by Indication
Neuropathic Pain
Fibromyalgia
Chronic Back Pain
Arthritic Pain
Migraine
Post-operative Pain
Cancer Pain
Global Pain Management Therapeutics Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific (APAC)
China
Japan
Rest of the World (RoW)
Brazil
Mexico
Request a sample of this report to know what opportunities will emerge in the rapidly evolving Pain Management Therapeutics Market during 2016- 2024
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059